ABSTRACT: Heifers with expected increased risk of bovine respiratory disease (BRD; n = 360; initial BW = 241.3 ± 16.6 kg) were assembled at a Kentucky order-buyer facility and delivered to Stillwater, OK, in September 2007 to determine the effects of clinical BRD observed during preconditioning on subsequent feedlot performance, carcass characteristics, and meat attributes. During a 63-d preconditioning period, morbidity and mortality attributed to BRD were 57.6 and 8.6%, respectively. Immediately after preconditioning, heifers were grouped according to health outcome category and allotted to finishing pens (5 to 7 heifers/pen). Heifers were never treated for BRD (0X; n = 9 pens), treated 1 time (1X; n = 9 pens), 2 times (2X; n = 6 pens), 3 times (3X; n = 6 pens), or designated as chronically ill (CI; n = 2 pens). Arrival BW was not different (P = 0.21) among treatment categories. However, disease incidence during preconditioning decreased (P < 0.001) growth, resulting in BW of 318, 305, 294, 273, and 243 kg for 0X, 1X, 2X, 3X, and CI, respectively, at the start of the finishing phase. Estimates on the LM, taken by ultrasound on d 65 and 122, were combined with BW and visual appraisal to target common average endpoint within category and block. On average, heifers were slaughtered on d 163 for 0X, 1X, and 2X, d 182 for 3X, and d 189 for CI (P < 0.01). Final BW was similar (P ≥ 0.18) for heifers treated 0, 1, 2, or 3 times, but heifers deemed CI weighed less (P = 0.01) than 3X heifers. Considering the finishing phase only, ADG was linearly increased (P < 0.001) with increasing BRD treatments, but was linearly decreased (P = 0.003) as BRD treatments increased from arrival to slaughter. Therefore, G:F was greater (P = 0.007) for CI than 3X and linearly increased (P = 0.002) from 0X to 3X. Similar to BW, HCW was less (P = 0.03) for CI than 3X. Marbling score tended (P = 0.06) to decrease linearly as the number of treatments increased, but no other differences (P ≥ 0.24) in carcass traits were detected. No differences were observed in beef tenderness (P = 0.65), and no consistent trends were noted in retail display or palatability data. Less than 20 additional days on feed were required for heifers treated 3 times to have similar BW and carcass characteristics to heifers never treated for BRD. Segregating animals with multiple BRD treatments and feeding them to an acceptable carcass endpoint may be a viable strategy for increasing value of animals treated for BRD.
INTRODUCTION
Bovine respiratory disease (BRD) resulted in 75% of morbidity and 50% of mortality in feedlot cattle (Edwards, 1996; Smith, 1998) . Costs associated with treatment, mortality, and decreased feed efficiency have been reported to cost the industry up to $750 million annually (Chirase and Greene, 2001) . Despite improved vaccines and antimicrobials, BRD rates have been increasing (Loneragan et al., 2001; Babcock et al., 2006) during recent years. Feedlot cattle that received 1, 2, or 3 treatments for BRD returned $40.64, $58.35, and $291.93 less, respectively, than untreated animals (Ful-ton et al., 2002) . A substantial portion (79%) of lost return was due to decreased carcass weight and reduced quality grade rather than treatment costs (Gardner et al., 1999) .
A 4% decrease in ADG, 1.7% decrease in final BW, and a 2.6% decrease in HCW were observed in steers treated for BRD (Gardner et al., 1999) . However, inconsistencies exist within BRD data. For example, ADG in morbid animals was similar to or greater or less than healthy animals (Roeber et al., 2001 ; Thompson et al., 2006) , and carcass characteristics were similar between treated and nontreated cattle (Waggoner et al., 2007) . These reports also differ in the rate and severity of BRD reported and the method of selecting slaughter endpoint. Furthermore, morbid and healthy animals were commingled throughout these experiments, and measures of DMI and efficiency were not possible. Therefore, the objectives of this study were to observe the effects of segregation of commingled, newly received heifer calves with an increased risk of developing BRD into BRD-outcome groups (never treated vs. number of times treated) on feedlot performance and carcass characteristics when heifers in outcome groups were fed to a similar compositional endpoint. An additional objective was to determine the effect of number of treatments for BRD on meat shelf-life, tenderness, and palatability.
MATERIALS AND METHODS
All procedures for the present experiment were approved by the Oklahoma State University Institutional Animal Care and Use Committee.
Cattle and Preconditioning Phase
Three hundred sixty British and British × Continental heifers (BW = 241.3 ± 16.6 kg) were assembled by Eastern Livestock at the West Kentucky Livestock Market (Marion). As each truckload of 90 heifers was assembled, heifers were identified with an individually numbered bangle tag, administered an electronic ruminal temperature monitoring bolus (SmartStock LLC, Pawnee, OK), and had a blood sample (10 mL) collected via jugular venipuncture for serum harvest (Clott activator, Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ). Heifers were then shipped 957 km to the Willard Sparks Beef Research Center (WSBRC), Stillwater, OK, in separate lots of 180 heifers each on September 11 and 13, 2007, respectively. Heifers were allowed to rest for 5 to 6 h after arrival without access to feed or water before initial processing. This consisted of individually weighing, collection of a skin sample (ear notch) for the detection of animals persistently infected with bovine viral diarrhea virus (PI-BVDV; Oklahoma Animal Disease Diagnostic Lab, Stillwater), and collection of a blood sample (10 mL) via jugular venipuncture for serum harvest (Clott activator, Becton Dickinson Vacutainer Systems). After collection, blood samples were transported to the laboratory where they were allowed to clot at 25°C for 3 h. After clotting, blood samples were centrifuged at 3,000 × g at 4°C for 20 min. Serum haptoglobin (Hp) concentration was measured using a bovine ELISA test (Immunology Consultants Lab, Portland, OR) . Samples were diluted 1:10,000 in Tris-buffered saline with Tween 20, pH 4.0 (Sigma, St. Louis, MO) before analysis. The intra-and interassay CV were <5%. Heifers were categorized into BRD risk groups based on arrival serum Hp concentrations and allocated within arrival lot into receiving pens 24 h after arrival for a 63-d preconditioning period. Groups were low (<1.0 μg/mL), medium (1.0 to 3.0 μg/mL), and high (>3.0 μg/mL) arrival Hp concentration.
Twenty-four hours after arrival, heifers were processed and sorted into their assigned pens based on arrival serum Hp concentrations as described above. Processing consisted of vaccination against infectious bovine herpes virus-1, bovine viral diarrhea virus (types I and II), bovine parainfluenza-3, and bovine respiratory syncytial virus (Pyramid 5, Fort Dodge Animal Health, Overland Park, KS), and clostridial pathogens (Vision 7 with Spur, Intervet/Schering-Plough Animal Health, DeSoto, KS), deworming with moxidectin (Cydectin, Fort Dodge Animal Health), and implanting with estradiol and trenbalone acetate (Component TE-G, Vetlife, Overland Park, KS). Three hundred thirty-seven of the 360 assembled heifers (BW = 241 ± 16.6 kg) were used in the experiment. Exclusion criteria included being PI-BVDV (n = 1), misidentification of initial blood samples, and laboratory errors (duplicate CV >5%) that required reruns which could not be performed within the 24 h between arrival and processing (n = 22). Heifers were fed in 6 pens (12.2 × 30.5 m with a 12.2-m fence-line concrete feed bunk and fence-line water basin) per arrival lot with an average of 28 animals (range = 18 to 34) per pen. Care was taken so that low-and high-Hp pens did not share a water basin. Heifers were fed twice daily, at 0700 and 1330 h, a 65% concentrate receiving/growing ration formulated to meet or exceed NRC (2000) nutrient requirements (Table 1) . Each morning before feeding, bunks were visually evaluated for the presence of orts and feed calls were adjusted so that less than 0.22 kg/heifer remained each morning. However, intakes of heifers were challenged every 2 to 4 d throughout the experiment to ensure that feed was offered for ad libitum consumption. On d 7, calves were individually weighed and revaccinated (Pyramid 5, Fort Dodge Animal Health). In addition to arrival and d 7, individual BW were recorded on d 14, 21, 42, and 63. the DART system (Pharmacia Upjohn Animal Health, Kalamazoo, MI) with some modifications as described by Step et al. (2008) . Subjective signs included evidence of depression (hanging head, sunken or glazed eyes, slow movement, arched back, difficulty in rising, knuckling or dragging toes when walking, and stumbling); abnormal appetite (completely off feed, eating less than or with less aggression than penmates, lack of fill, or obvious BW loss); and respiratory signs (obvious labored breathing, extended head and neck, and noise when breathing). Based on the presence of 1 or more of these signs, and the severity of the sign(s), the evaluators assigned a severity score from 1 to 4, where 1 was mild, 2 was moderate, 3 was severe, and 4 was moribund. All calves assigned a severity score were removed to the processing chute for rectal temperature (Temp) measurement (GL M-500, GLA Agricultural Electronics, San Luis Obispo, CA). For animals assigned a severity score of 1 or 2, antimicrobial therapy was administered according to protocol if Temp was ≥40.0°C. However, animals assigned severity scores of 3 or 4 were administered antimicrobial therapy regardless of Temp. A maximum of 3 antimicrobial therapies (treatments) were allowed during the experiment, and all doses were calculated by rounding the current BW up to the nearest 11.3 kg. Antimicrobials were administered in the neck following Beef Quality Assurance Guidelines (NCBA, 2001 ) via a subcutaneous injection. The first antimicrobial treatment was administered in the left neck, and subsequent injections were given in alternating sides of the neck. When treatment criteria were met the first time, 10 mg of tilmicosin/kg of BW (Micotil 300, Elanco Animal Health, Greenfield, IN) was administered. A moratorium after tilmicosin administration was observed before a second antimicrobial treatment could be given. This moratorium was 120 h for a severity score of 1 or 2, and 72 h for a severity score of 3 or 4. If severity and Temp criteria were met as described above, 10 mg of enrofloxacin/kg of BW was administered (Baytril 100, Bayer Animal Health, Shawnee Mission, KS) for a second antimicrobial treatment. After a 48-h period, heifers meeting treatment criteria were eligible to receive ceftiofur hydrochloride (Excenel RTU, Pfizer Animal Health, New York, NY). Excenel therapy consisted of 2 doses (2.2 mg/kg of BW) given 48 h apart. When subjective and Temp criteria were not met, no antimicrobial was administered, and treated and not treated animals were returned to their home pens after evaluation.
Beginning on d 21 and each day after, standards for defining chronically ill (CI) animals were instituted, and those animals identified as CI were removed from their home pens. To be defined as CI, an animal must have previously been administered all 3 antimicrobial therapies according to protocol and at least 48 h had passed after the last dose of Excenel was given. The animal must have been on study longer than 21 d and have a net loss of BW over the most recent 21-d period. In addition, the heifer must have been assigned a severity score of 3 or 4 on the day the heifer was removed from her home pen.
Finishing Phase
After the 63-d preconditioning phase, 193 heifers were selected to begin the finishing phase of the experiment. All calves were classified according to the number of antimicrobial treatments for BRD they had received during the preconditioning phase and assigned to the following outcome groups: never treated (0X), treated 1 time (1X), treated 2 times (2X), treated 3 times (3X), and heifers identified as CI. Heifers were automatically excluded from the finishing phase if they were visually lame (n = 1) or treatment protocol was not followed during the preconditioning phase (n = 5). All heifers that qualified in the 2X (n = 34), 3X (n = 39), and CI (n = 12) groups were used in the finishing phase. For the 0X and 1X groups, heifers were stratified within group by d-63 BW and 54 heifers from each group were randomly selected for the finishing period using a random number generator maintaining a similar BW distribution between the total number of heifers and the sample selected. Within all outcome groups, heifers were then blocked by BW (light and heavy within outcome group) and randomly assigned to feedlot pens within outcome group and BW block. Nine pens each were used for 0X and 1X (n = 6 heifers/pen), 6 pens each were used for 2X and 3X (n = 5, 6, or 7 heifers/pen), and 2 pens were used for CI (n = 6 heifers/pen). Pens were 4.57 × 15.24 m with a 4.57-m fence-line feed bunk and 4.57-m deep concrete apron extending into the pen. Feed bunks and aprons were covered with a metal awning. Adjacent pens shared a fence-line automatic water basin. Heifers had 9.9 to 13.9 m 2 of pen space and 65 to 91 cm of bunk space available per animal. Three or five days after the final BW from the preconditioning experiment (d 0), heifers were individually weighed, implanted with estradiol and trenbalone acetate (Revalor-IH, Intervet/ Schering-Plough Animal Health), and sorted into their final pens. Over the next 19 d, a series of 3 diets with increasing concentrate density was fed until the heifers were adapted to the final finishing diet (Table 1) . Similar to the preconditioning phase, cattle were fed twice daily beginning at 0700 and 1330 h, respectively, and bunks were managed such that no orts or less than 0.22 kg/animal remained before feeding each morning.
Body weights were recorded on d 28, 65, 100, 122, 152, 174, and 189. On d 65 and 122, all animals had LM and 12th-rib fat characteristics estimated by ultrasonography (C. Gordon, Ultrasound Technologies, Fletcher, OK). Estimated characteristics included LM area, fat thickness (FT), and percent intramuscular fat (IMF). Based on these estimates, BW gain, and visual appraisal, heifers were targeted for slaughter at equal compositional endpoints. Within BRD treatment category and BW block, average 12th-rib FT was targeted to be 1.27 cm, and body composition was estimated visually to have sufficient body fat to grade US Choice. Slaughter dates were common for all pens in the same BRD outcome group within BW block. Final BW were obtained before feeding 1 d before slaughter, after which animals were returned to their home pens and fed 75% of the allotment of feed from the previous day. Trucks were loaded at approximately 1700 h and heifers were hauled 478 km to a commercial abattoir for slaughter the next morning.
Lung Lesion Assessment
The presence and severity of lesions on the lungs as evidence of prior bronchopneumonia of heifers were determined using a scoring procedure based on that of Bryant et al. (1999) . Lungs were scored in the abattoir at chain speed using visual appraisal and brief palpation. The same individual scored lungs on each of the 3 slaughter dates. For each side (right and left) the presence and severity (0, 1, 2, 3) of lesions were recorded, along with the absence or presence (0, 1) of interlobular adhesions or missing lobes indicating thoracic adhesions. Overall evidence of bronchopneumonia (0, 1) was based on the presence of a lesion, adhesion, or missing lobe for each side and the overall lung. At slaughter, HCW was recorded and the frequency (0, 1) of condemned livers was also observed.
Carcass Characteristics and Meat Quality Sample Collection
After a 36-h chill, carcasses were graded and fabricated according to Institutional Meat Purchasing Specifications (USDA, 1996) . Trained personnel from Oklahoma State University collected carcass data which included HCW, LM area, marbling score, maturity scores, KPH, and 12th-rib FT. Yield grade was calculated from HCW, LM area, 12th-rib fat, and KPH; and quality grade was determined from marbling score and maturity data. The same individual assessed subjective carcass measures for each slaughter group. A strip loin was fabricated from each carcass, vacuum packaged, and transported to the Robert M. Kerr Food and Agricultural Products Center (Stillwater, OK) for further analysis. Strips were aged for 14 d in the vacuum package bag at 3 ± 1°C. After aging, 1 steak from each carcass was cut (2.54 cm) for retail display analysis, and 2 steaks were cut (2.54 cm), vacuum packaged, and frozen in a blast freezer (−20 to −40°C); frozen samples were held in a freezer (−10°C) until further WarnerBratzler shear force (WBSF) and sensory analysis.
Retail Display and Color Analysis
An open-topped, coffin-chest display case (M1-8EB, Hussman, Bridgeton, MO) maintained between 2 and 4°C was used to simulate retail display of packaged steaks. Steaks were packaged on a styrofoam tray with soaker pad and overwrapped with polyvinyl chloride film. Packages were displayed under continuous, 1,600 lx of cool-white fluorescent lighting (Bulb No. F40 T12, Promolux, British Columbia, Canada) . Beginning at 0 h under display conditions and every 12 h for 108 h, each package was subjectively evaluated by a trained panel containing 6 panelists. Packages were rotated daily, such that they were exposed to all conditions of light angles and intensities and environmental effects associated with defrost cycle and location within the case. Muscle color, surface color, and overall ap-pearance were evaluated (AMSA, 1991) . Muscle color was characterized on an 8-point scale (1 = extremely dark red, 2 = dark red, 3 = moderately dark red, 4 = slightly dark red, 5 = slightly bright cherry red, 6 = moderately bright cherry red, 7 = bright cherry red, and 8 = extremely bright cherry red). Scores for surface discoloration were assigned based on a 7-point scale [1 = no (0%) discoloration, 2 = slight (1 to 19%) discoloration, 3 = small (20 to 39%) discoloration, 4 = modest (40 to 59%) discoloration, 5 = moderate (60 to 79%) discoloration, 6 = extensive (80 to 99%), and 7 = total (100%) discoloration]. Overall appearance was scored on an 8-point scale (1 = extremely undesirable, 2 = very undesirable, 3 = moderately undesirable, 4 = slightly undesirable, 5 = slightly desirable, 6 = moderately desirable, 7 = very desirable, and 8 = extremely desirable). Similarly, steaks were objectively evaluated for instrument color beginning at 0 h under display conditions and every 12 h thereafter for 108 h. The color of each steak was measured using a HunterLab Miniscan XE Plus Spectrophotometer (2.50-cm aperture, 10° standard observer, Illuminant D65, HunterLab Associates Inc., Reston, VA). 
Sensory Analysis
For sensory analysis, steaks were allowed to thaw at 4°C for 24 h before cooking and broiled at 200°C on an impingement oven (ZLT Impinger, model 3240-TS, BOFI Inc., Wichita, KS). After reaching an internal temperature of 68°C (Atkins AccuTuff 340, Atkins Temtec, Gainesville, FL), steaks were sliced into 2.54-cm × 1.27-cm × 1.27-cm samples. Panelists (n = 7) that had previously been trained according to AMSA (1995) guidelines evaluated warm samples for initial and sustained juiciness, initial and overall tenderness, and amount of connective tissue using an 8-point scale.
Panelists evaluated cooked beef flavor, painty/fishy, and livery/metallic off-flavor intensity using a 3-point scale. For juiciness, the scale was 1 = extremely dry, 2 = very dry, 3 = moderately dry, 4 = slightly dry, 5 = slightly juicy, 6 = moderately juicy, 7 = very juicy, and 8 = extremely juicy. The scale used for initial and overall tenderness was 1 = extremely tough, 2 = very tough, 3 = moderately tough, 4 = slightly tough, 5 = slightly tender, 6 = moderately tender, 7 = very tender, and 8 = extremely tender. The scale used for connective tissue was 1 = abundant, 2 = moderately abundant, 3 = slightly abundant, 4 = moderate, 5 = slight, 6 = traces, 7 = practically none, and 8 = none. The scale used for beef flavor and off-flavor intensity was 1 = not detectable, 2 = slightly detectable, and 3 = strong.
WBSF
Before WBSF determination, steaks were thawed and cooked as described above. After cooking, steaks were cooled at 4°C for 18 to 24 h. Six cores, 1.27 cm in diameter, were removed parallel to muscle fiber orientation and sheared once using a Warner-Bratzler head attached to an Instron Universal Testing Machine (model 4502, Instron Corporation, Canton, MS). The WarnerBratzler head moved at a crosshead speed of 200 mm/ min. Peak load (kg) of each core was recorded by an IBM PS2 (model 55 SX) using software provided by the Instron Corporation. Mean peak load (kg) was analyzed for each of the 6 cores and was then averaged over the sample to determine the WBSF for the sample.
Statistical Analysis
Animal performance and carcass characteristics were analyzed considering pen as the experimental unit. Blocks were established by dividing the heifers within each BRD-outcome group into a light and heavy group resulting in 2 blocks for each of the 5 BRD-outcome categories. Because of the unequal numbers of heifers in each group there were 5 and 4 pens of 0X heifers, 5 and 4 pens of 1X heifers, 3 and 3 pens of 2X heifers, 3 and 3 pens of 3X heifers, and 1 and 1 pen of CI heifers in the heavy and light blocks, respectively. The Brown-Forsythe method was used to test for homogeneity of variances and was significant (P < 0.05) for multiple variables. Therefore, mixed models were used to analyze continuous performance and carcass characteristics data (PROC MIXED, SAS Inst. Inc., Cary, NC). The model statement included BRD outcome group as a fixed effect, and the Kenward-Rogers degrees of freedom were specified. The random statement included BW block. Heifers were not allocated into finishing pens until after the preconditioning phase and, therefore, preconditioning-phase data could not be analyzed using pen as the experimental unit. Because performance during the time period when morbidity occurred is important to the overall understanding of the impact of BRD, we analyzed preconditioning-phase data (arrival BW, preconditioning-phase ADG, and arrival to end ADG) using individual animal as the experimental unit.
Nonparametric data (proportion of carcasses in quality and yield grades and proportion of lungs with lesions present) were analyzed as binomially distributed using the logit link with the GLIMMIX procedure of SAS with the mixed model listed above. Least squares means were calculated as logits and transformed into frequency estimates and SE using SAS. Because this approach views the multinomial distribution of USDA quality grades, for example, as a series of binomial proportions, inference should not be made between categories of a particular variable.
Meat quality data were analyzed as a completely randomized block design with the MIXED procedure of SAS. Because treatments for clinical BRD were administered to individuals, individual animal was considered the experimental unit for meat quality data. The model statement contained the fixed effect of BRD outcome category, and the random statement included slaughter group (1, 2, or 3). Repeated measures analysis was used to analyze objective and subjective measures of retail display characteristics. The model was subjected to multiple covariance structures, and the best fit model was selected to contain the covariance structure that yielded the smaller Akaike and Schwarz's Bayesian criterion based on their -2 res log-likelihood. With the exception of L*, which was analyzed using a heterogeneous Toeplitz covariance structure, all other variables of objective and subjective retail display were analyzed using a first order ante-dependence covariance structure.
For all analyses, contrasts were used to test the linear and quadratic responses of increasing the number of treatments for BRD from 0 to 3. Polynomial contrast coefficients were weighted to compensate for unequal sample sizes. In addition, the response of receiving 3 treatments for BRD was contrasted against that of heifers deemed CI. To control type I error rate when using contrasts which are not mutually orthogonal, differences or tendencies are only discussed when the probability associated with the F-statistic is ≤0.05 or ≤0.10, respectively.
RESULTS
Morbidity attributed to clinical signs of BRD was 57.6%, and total mortality was 8.6%. The case fatality rate was 13.1%. Based on the selection criteria described above, 54, 54, 34, 39, and 12 heifers were enrolled in 0X, 1X, 2X, 3X, and CI pens, respectively. Descriptive statistics including mean days on feed at the time of each treatment, removal or mortality, severity score, serum Hp concentration, and Temp at time of treatment are shown in Table 2 . During the finishing period, 2 heifers met criteria and were treated for signs of BRD with 2 doses of 6 mg/kg of danofloxacin mesylate (A180, Pfizer Animal Health) administered 48 h apart. One heifer from the 2X treatment was treated on d 149 and remained in her home pen for the duration of the experiment. One heifer from the CI treatment was removed from her home pen on d 94 due to the severity of clinical signs of BRD and was treated and died on d 97. Three additional heifers died from digestive causes during the finishing phase (1 heifer each from 0X, 3X, and CI treatments).
Body weight upon arrival at the facility was not different (P = 0.17) between heifers that had differing numbers of subsequent treatments for BRD (Table 3) .
However, after the 63-d preconditioning period (d 0 of finishing), there was a linear decrease (P < 0.001) in BW as the number of treatments for BRD increased from 0 to 3. The range in mean BW for those categories was 45 kg. Furthermore, BW was 30 kg less (P < 0.001) for CI heifers compared with 3X heifers. Similar linear decreases (P < 0.001) in BW were observed through d 122 during finishing, although the difference between heifers never treated for BRD and those 3X heifers was 35 kg. The difference in BW between 3X heifers and heifers deemed CI remained large (43 kg) after 122 d on feed. When averaged across days on feed, no trend (P ≥ 0.18) could be determined to separate final BW of heifers, regardless of BRD treatment category. However, CI heifers were 29 kg lighter (P = 0.01) than 3X immediately before slaughter. Average daily gain was not different (P ≥ 0.13) among heifers treated different times for BRD from d 29 to 65, 66 to 122, 123 to end, or 0 to end. Chronically ill heifers gained less BW (P ≤ 0.006) than 3X during d 0 to 28 and 0 to 65, but overall finishing period ADG was similar (P = 0.38) between 3X and CI. When the preconditioning period was included and ADG calculated, there was a linear decline (P = 0.008) in ADG as the number of treatments for BRD increased. In addition, the overall ADG of CI heifers (1.06 kg/d) was less (P = 0.05) than those requiring 3 BRD treatments.
During d 0 to 28 of finish, there was a quadratic (P = 0.002) response in DMI as the number of treatments for BRD increased from 0 to 3, and CI was less (P = 0.02) than 3X (Table 3) . A linear decrease (P < 0.001) in DMI with increasing BRD treatments was noted from d 0 to 65, but overall DMI was not different (P ≥ 0.13) due to the number of BRD treatments (0X to 3X). Dry matter intake remained less (P < 0.001) for CI than 3X during d 29 to 65 and was less (P = 0.007) for CI than 3X across the entire finishing period. When DMI was expressed as a percent of mean BW (DMIBW), there was a quadratic effect (P = 0.01) from d 0 to 28 in which 2X steers consumed more than 0X, 1X, or 3X. Later in the feeding period (d 123 to end), there was a linear increase (P = 0.03) in DMIBW as the number of BRD treatments increased from 0 to 3. However, overall DMIBW was similar (P = 0.60) among BRD treatments from d 0 to end. Due to the similar ADG and decreased DMI observed between BRD treatment categories, G:F was increased (linear, P ≤ 0.002) as number of treatments increased during d 0 to 28 and 0 to 65. The increase in G:F tended (P = 0.07) to continue from d 66 to 122. Heifers identified as CI were more (P ≤ 0.01) efficient than 3X during d 0 to 28 and 66 to 122. Overall G:F was increased (linear, P = 0.002) from 0.152 to 0.168 as the number of BRD treatments increased from 0 to 3. Day 0 to end G:F for CI heifers was 0.186 (3 vs. CI; P = 0.04).
The area of the LM, estimated by ultrasonography, linearly decreased (P = 0.01) as the number of BRD treatments increased from 0 to 3 on d 65, but was not different (P ≥ 0.31) on d 122 (Table 4) . However, CI heifers had smaller estimated LM area (P ≤ 0.02) than 3X, both on d 65 and 122. The difference was 15.2 cm 2 on d 65, but only 9.3 cm 2 on d 122. On both d 65 and 122, the percent IMF estimates tended to be linearly decreased (P ≤ 0.09) as the number of treatments for BRD were increased, but no differences (P ≥ 0.20) in percent IMF were detected between 3X and CI heifers at either ultrasound measurement. In addition, estimated 12th-rib FT was decreased linearly (P ≤ 0.001) as the number of BRD treatments increased, and CI heifers had approximately 0.2 cm less 12th-rib FT (P ≤ 0.02) on d 65 and 122.
At the time slaughter when carcass characteristics were measured, similar to final BW, HCW was not different (P ≥ 0.21) among BRD treatment categories, but was decreased (P = 0.007) in CI compared with 3X heifers (Table 4) . No difference (P = 0.31) in dressing percent, which ranged from 61.7 (CI) to 63.8 (1X), was detected. Marbling score tended (P = 0.10) to decrease (linear, P = 0.06) as the number of treatments for BRD increased. No other differences (P ≥ 0.24) in carcass characteristics were observed due to number of treatments for BRD or chronic status. Similarly, the distribution of heifers in USDA Quality and Yield grades was not different (P ≥ 0.40) among treatments (Table 5) .
Overall evidence of previous pneumonia observed in the lungs at slaughter was not different (P = 0.59) among BRD treatment categories (Table 6) . Similarly, there were no differences (P ≥ 0.25) in the frequencies of severe lung lesions, interlobular adhesions, missing lobes, nor were any pulmonary lesion attributes observed in the left or right lungs individually corresponding to the number of BRD treatments.
Retail display characteristics of strip loin steaks are shown in Table 7 . There were BRD treatment category × time interactions (P < 0.001) for muscle color and overall appearance of retail display characteristics of steaks (data not shown). As expected, muscle color decreased, surface discoloration increased, and desirability overall appearance diminished (P < 0.001) over time. However, no pattern in the decline of color or overall 1 Percentages were calculated by dividing by the total number of heifers enrolled in the study (n = 337). However, health outcome categories do not include animals removed from their home pens due to lameness (n = 6, 1.78%) or heifers not included in the finishing phase due to treatment protocol noncompliance (n = 5, 1.48%).
2 DOF = number of days on feed during the preconditioning phase; CAS = clinical attitude score (0 to 4); Temp = rectal temperature (°C); Hp = serum haptoglobin concentration (μg/mL).
3 Bovine respiratory disease (BRD) treatment category during the preconditioning phase: 0X = never treated; 1X = treated 1 time for signs of BRD; 2X = treated 2 times for signs of BRD; 3X = treated 3 times for signs of BRD; CI = deemed chronically ill; Dead = BRD mortalities. 4 Of the 27 mortalities, 25 were case fatalities (case fatality rate = 13.1%). Days on feed data include all animals treated at least 1, 2, or 3 times or were classified as CI and subsequently died. Case fatalities occurred for cattle that were treated 1 (n = 4), 2 (n = 1), or 3 (n = 2) times and for calves classified as CI (n = 18).
5 Data reported according to the time each heifer received its first, second, or third antimicrobial treatment for BRD, was classified as CI and removed from its home pen, or died. appearance due to BRD treatment category was apparent. As the number of BRD treatments increased, a linear decrease (P = 0.01) in muscle color was observed. A quadratic response in surface discoloration tended (P ≤ 0.07) to occur, with steaks from 2X heifers having greater discoloration. Significant BRD treatment category × time interactions were observed for L*, a*, and b* measures of color (P < 0.001; data not shown). No differences (P = 0.65) in WBSF were observed due to BRD treatment history (Table 8) . Steaks from CI carcasses tended (P = 0.06) to have less initial juiciness than steaks from 3X carcasses. However, no other differences (P ≥ 0.15) in palatability measures were observed.
DISCUSSION
The overall morbidity attributed to clinical signs of BRD (57.6%) fell within the range of expected morbidity rates for calves with similar background. In recent experiments at the WSBRC, observed total morbidity rates in newly received, auction-market-sourced calves Table 3 . Finishing performance of heifers that received 0, 1, 2, or 3 treatments for bovine respiratory disease (BRD) or were deemed chronically ill (CI) during the preconditioning phase BRD treatment category during the preconditioning phase: 0X = never treated; 1X = treated 1 time for signs of BRD; 2X = treated 2 times for signs of BRD; 3X = treated 3 times for signs of BRD.
3 SE of the least squares means (n = 9 pens for 0X and 1X; n = 6 pens for 2X and 3X; n = 2 pens for CI). Largest SEM shown. 4 Probability of the overall F-test. Arr. = day of arrival at the facility (heifers were received 63 to 65 d before beginning the finishing phase). Because heifers were not allocated into finishing pens until after the preconditioning phase, individual animal was used as the experimental unit for variables that involve arrival BW and preconditioning-phase ADG. Bovine respiratory disease ranged from approximately 2.5% (group 1; Step et al., 2007) to 64.0% (Berry et al., 2004) . Edwards (1996) reported that BRD contributed to 75% of the morbidity in feedlots and that total morbidity from all causes was consistently around 8% of all feedlot cattle received. Loneragan et al. (2001) reported 1.2% mortality, of which 57.1% was attributed to respiratory disease, in cattle received into the USDA-NAHMS sentinel feedlot monitoring program between 1994 and 1999. The greater morbidity and mortality of cattle in the pres- Table 4 . Ultrasound estimates and carcass characteristics of heifers that received 0, 1, 2, or 3 treatments for bovine respiratory disease (BRD) or were deemed chronically ill (CI) during the preconditioning phase 1 BRD treatment category during the preconditioning phase: 0X = never treated; 1X = treated 1 time for signs of BRD; 2X = treated 2 times for signs of BRD; 3X = treated 3 times for signs of BRD.
2 SE of the least squares means (n = 9 pens for 0X and 1X; n = 6 pens for 2X and 3X; n = 2 pens for CI). Largest SEM shown. 3 Probability of the overall F-test. 4 Significance of contrasts: LIN = linear effects of number of BRD treatments; QUAD = quadratic effects of number of BRD treatments; 3 vs. CI = 3X vs. CI heifers.
5 Intramuscular fat. 6 12th-rib fat thickness. 7 Days on feed during the finishing phase. 8 300 = slight 0; 400 = small 0; 500 = modest 0. 1 BRD treatment category during the preconditioning phase: 0X = never treated; 1X = treated 1 time for signs of BRD; 2X = treated 2 times for signs of BRD; 3X = treated 3 times for signs of BRD.
2 Standard error of the least squares means (n = 9 pens for 0X and 1X; n = 6 pens for 2X and 3X; n = 2 pens for CI). Largest SEM shown. 3 Probability of the overall F-test. 4 Significance of contrasts: LIN = linear effects of number of BRD treatments; QUAD = quadratic effects of number of BRD treatments; 3 vs. CI = 3X vs. CI heifers. 5 Yield grade and quality grade as determined by USDA graders.
ent experiment compared with the averages reported by surveys is resultant from the surveys including all cattle received into feedlots: both high risk and low risk (Edwards, 1996; Loneragan et al., 2001 ). Nevertheless, commercial operations have reported increased morbidity rates (80%; Sanderson et al., 2008) in individual pens of cattle. One advantage to the increased morbidity and numbers of animals requiring multiple treatments observed in the present experiment is the ability for replicating these outcome categories for the finishing phase of the experiment. This provided an excellent model with which to test our objectives. We chose a preconditioning period of 63 d before classifying the heifers according to BRD outcome group. Reasons for this decision were related to arrival BW and the increased likelihood that the majority of BRD treatments, including multiple treatments when necessary, would occur within the 63-d time period.
The average arrival BW of 241 kg would be common for fall-weaned calves in the United States. Expecting an approximate 1 kg of ADG during the preconditioning period, heifers would then have appropriate BW to expect a 150-to 175-d finishing period, typical of commercial feedlots. Experience in our facility suggests that both initial and subsequent treatments for clinical BRD would virtually cease by the end of the 63-d preconditioning phase. This approach is also supported by the literature. For example, Thompson et al. (2006) observed that 87% of all BRD treatments had occurred by 35 d after arrival, and 74% of morbidity during a 5-yr survey of a commercial feedlot occurred within the first 42 d on feed ). The mean days after arrival to first treatment in that study were 30, but new cases peaked within 14 d of arrival . In the present experiment, the mean days after arrival to first treatment were less than approxi- Table 6 . Distribution of pulmonary lesions observed at slaughter from heifers that received 0, 1, 2, or 3 treatments for bovine respiratory disease (BRD) or were deemed chronically ill (CI) during the preconditioning phase Lungs scored at chain speed in the plant using a scoring procedure based on that of Bryant et al. (1999) .
2 BRD treatment category during the preconditioning phase: 0X = never treated; 1X = treated 1 time for signs of BRD; 2X = treated 2 times for signs of BRD, 3X = treated 3 times for signs of BRD.
3 SE of the least squares means (n = 9 pens for 0X and 1X; n = 6 pens for 2X and 3X; n = 2 pens for CI). Largest SEM shown. 4 Probability of the overall F-test.
5
Significance of contrasts: LIN = linear effects of number of BRD treatments; QUAD = quadratic effects of number of BRD treatments; 3 vs. CI = 3X vs. CI heifers. Table 7 . Visual and instrument attributes of strip loin steaks from heifers receiving 0, 1, 2, or 3 treatments for bovine respiratory disease (BRD) or heifers deemed chronically ill (CI) during the preconditioning phase BRD treatment category during the preconditioning phase: 0X = never treated; 1X = treated 1 time for signs of BRD; 2X = treated 2 times for signs of BRD, 3X = treated 3 times for signs of BRD.
2 SE of the least squares means (n = 9 pens for 0X and 1X; n = 6 pens for 2X and 3X; n = 2 pens for CI). Largest SEM shown. Surface discoloration: 1 = total discoloration (100%), 7 = no discoloration (0%).
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Overall appearance: 1 = extremely undesirable, 8 = extremely desirable. BRD treatment category × time of display interaction, P < 0.001. Similar to the present experiment, arrival BW has often not differed between cattle that were never treated and those that required antimicrobial treatment for signs of BRD (Gardner et al., 1999; Waggoner et al., 2007) . Similarly, initial BW has been reported to have no effect on the success of BRD antimicrobial treatment or relapse rate (Bateman et al., 1990) . However, a linear decrease in arrival BW was reported for heifers treated 0 to 3 times (Montgomery et al., 2009 ). In addition, the linear decrease in BW associated with increasing treatments for BRD after the 63-d preconditioning period is supported by previous data (Gardner et al., 1999; Thompson et al., 2006; Schneider et al., 2009) . A difference between the present experiment and that of Gardner et al. (1999) is that the cattle in their study were all slaughtered on d 150 or 151, and this date was presumably determined based on the average visual composition of cattle in the study. The use of ultrasonography combined with animal performance and visual appraisal allowed us to slaughter heifers when each BRD outcome category was expected to have 1.27 cm of backfat over the 12th rib. Therefore, heifers in the 3X and CI groups were fed an average 19 and 26 d longer, respectively, than 0X, 1X, and 2X heifers. Because of this, final BW in our experiment was not different between 0X and 3X heifers. Roeber et al. (2001) and Waggoner et al. (2007) evaluated animals enrolled in the Rocky Mountain (Roeber et al., 2001) and New Mexico (Waggoner et al., 2007) Ranch to Rail programs where animals were slaughtered on a marketready basis. Similarly, final BW was not different between animals administered differing numbers of BRD treatments. Waggoner et al. (2007) reported the mean days on feed of cattle that were never treated (193 d), treated one time (200 d), and treated 2 or more times (212 d). Whereas we slaughtered all 0X, 1X, and 2X heifers at the same time, the 19-d difference between healthy calves and those treated 2 or more times in the study of Waggoner et al. (2007) is consistent with the present experiment.
Preconditioning-phase and overall (arrival to end) ADG are consistent with other reports with heifers treated 3 times having 59 and 8.7% less ADG than heifers who remained healthy throughout the feeding period, respectively. After the small preconditioningphase BW gain by morbid animals, a compensatory response was noticed in those animals, such that overall finishing-phase ADG was similar across BRD treatment categories. This finding is similar to Thompson et al. (2006) who observed a 169-g decrease in ADG during the first 35 d on feed by morbid animals, but no difference in ADG from d 35 to slaughter. Decreased ADG by morbid animals during the receiving phase was followed by increased ADG on grass (Montgomery et al., 2009) , and ultimately equivalent ADG in the feedlot (Montgomery et al., 2009; Schneider et al., 2009 ). Although we did observe a compensatory response in ADG during the finishing phase, it is important to note that 3X and CI heifers never fully compensated, and the similar final BW observed between 0X, 1X, 2X, and 3X heifers was measured with an average of 19 additional days on feed for 3X heifers.
Existing data investigating the effects of BRD on feedlot cattle performance are derived primarily from correlating cattle performance with treatment records in a commercial feedlot. The present experimental design allowed us to measure DMI of feedlot cattle that BRD treatment category during the preconditioning phase: 0X = never treated; 1X = treated 1 time for signs of BRD; 2X = treated 2 times for signs of BRD, 3X = treated 3 times for signs of BRD.
2 SE of the least squares means (n = 9 pens for 0X and 1X; n = 6 pens for 2X and 3X; n = 2 pens for CI). Largest SEM shown. had required differing numbers of treatments for BRD during preconditioning. We were unable to quantify feed intake by BRD outcome category during the time when the animals were exhibiting clinical signs and administered treatment, but previous data suggest that the morbid calves in our study were likely consuming less DM than healthy animals. For example, calves identified as morbid were less likely to visit the feed bunk on d 1 (Sowell et al., 1999) or during the first 7 d on feed (Hutcheson and Cole, 1986 ) after arrival into a feedlot. These observations can contribute to morbid animals having only 58, 68, and 88% of the DMI compared with healthy animals during wk 1, 4, and 8, respectively, after arrival into a feedlot (Hutcheson and Cole, 1986) . If the heifers in our experiment behaved similarly to calves in previous reports (Hutcheson and Cole, 1986; Sowell et al., 1999; Buhman et al., 2000) , the linear decrease in preconditioning phase ADG observed in the present experiment by calves that required more treatments for clinical BRD could be the result of less frequent visits to the feed bunk and less DMI by morbid calves.
Morbid steers in the experiment of Gardner et al. (1999) , similar to most commercial feedlots, were maintained in a hospital pen for a minimum of 3 d each time they were removed for BRD treatment. Gardner et al. (1999) noted that while in hospital pens, the calves were fed diets containing more hay and, thus, less NE. Therefore, decreased feed intake, decreased energy intake, or a combination of the 2 could explain the decreased ADG and BW of the morbid calves in their study. In the present experiment, after animals were removed to the chute for Temp evaluation and antimicrobial treatment, they were returned to their home pen. Therefore, all calves received the same diets during the preconditioning and finishing phases, respectively, and differences in energy intake not resultant from differences in DMI were not the cause of decreased ADG observed by morbid animals in the preconditioning phase. An exception was the heifers deemed CI, who were removed according to the described protocol. These heifers were fed the same growing diet along with additional grass hay to stimulate intake in pens designated for CI animals after they were removed from their home pens. No other calves removed from the home pen for an extended period of time were enrolled in the finishing portion of the present experiment.
One of the goals in the present experiment was to harvest all animals at a similar target endpoint. Using a combination of animal performance, ultrasound estimates, and visual assessment based on 12th-rib fat and carcass fatness, we were successful at meeting our similar endpoint goal. Final BW and HCW were not different among animals treated from 0 to 3 times for clinical signs consistent with BRD. In addition, only a 0.14-cm difference in 12th-rib FT was observed between heifers across treatment categories, not including CI heifers. Heifers that had been classified as CI had less final BW and HCW. Due to the desired sample collection and the distance of the abattoir from the research feedlot, logistical concerns compelled us to slaughter both blocks of the CI heifers earlier than preferred, on d 189. Given the average performance of the CI pens from d 152 to 189 (ADG = 1.15 kg/d; DMI = 8.97 kg/d; G:F = 0.129), it is reasonable to assume similar final BW and carcass characteristic endpoints would have been achievable for those animals in less than 30 more days on feed. Aside from the performance differences highlighted between 3X and CI treatments, the lack of differences in all carcass traits relative to BRD treatment status indicates that given the time and necessary energy intake, surviving morbid animals may reach their potential to produce a similar product to animals that remain healthy throughout the entire feeding period.
In the present experiment, no differences in HCW, FT, LM area, internal fat, or yield grade were observed; however, a linear trend of decreasing marbling score occurred as the number of BRD treatments increased. McNeill et al. (1996) reported only 27% of cattle who had been treated for BRD in feedlots graded US Choice, and Schneider et al. (2009) reported 16% fewer animals from BRD treatment groups graded US Choice than did nontreated animals, similar to the present experiment. In addition, those that required multiple treatments (3) were 5 times more likely to grade US Standard than nontreated cattle (McNeill et al., 1996) . Therefore, although compensatory growth seems plausible for morbid cattle, IMF and quality grade may lag behind nontreated contemporaries.
No trend in the presence or severity of respiratory tract lesions between treated and nontreated animals was observed in this study. Similarly, in previous reports, the presence of lesions was inconsistent with treatment records (Gardner et al., 1999; Buhman et al., 2000; Thompson et al., 2006) . Although Wittum et al. (1996) and Bryant et al. (1999) indicated that the presence of pulmonary lesions was a better predictor than treatment records for BRD-caused losses in ADG, the differences in preconditioning phase final BW and ADG, combined with the observed increased Hp concentrations and Temp observed at the time of treatment, indicate that administered treatments were related to infection in the present experiment. Therefore, although pulmonary lesion data are similar between BRD-outcome categories, measuring finishing performance and carcass characteristics according to treatment for clinical signs is appropriate and relevant to the current ability of cattle feeders to classify BRD in the field.
Effect of BRD history on palatability and meat tenderness measures has been reported (Gardner et al., 1999; Roeber et al., 2001; Snowder et al., 2007) . Consistent with the present study, previous treatment for BRD was not associated with decreased tenderness. However, after 7 d of aging, Gardner et al. (1999) observed increased WBSF in LM from steers that exhibited respiratory tract lesions, but no differences were observed after 14 or 21 d of aging. The tendency for decreased initial juiciness in strip steaks from heifers that had been classified as CI during the preconditioning phase may be related to the numerically less marbling observed in those heifers. Roeber et al. (2001) showed no differences in palatability traits according to BRD treatment group even with a statistically significant decrease in marbling by treated animals. Similarly, Snowder et al. (2007) did not observe a significant correlation between respiratory disease and WBSF, or tenderness, juiciness, and flavor scores. However, no differences in marbling were observed in those cattle.
In conclusion, clinical BRD resulted in decreased BW and ADG during the preconditioning phase. However, after segregation according to previous BRD treatments during finishing, a compensatory response in ADG and G:F was observed in treated animals. Slaughter date selection for each BRD treatment group by objective and subjective measures was successful in reaching similar compositional endpoints between heifers that were never treated and those that required up to 3 BRD treatments. Days on feed required to reach similar carcass endpoints were similar for heifers that were never treated, treated 1 time, and treated 2 times, and approximately 18 additional days were required for heifers treated 3 times to have a similar carcass endpoint. When slaughtered at a common endpoint, heifers, regardless of the number of BRD treatments, had similar final BW, carcass weights, and carcass characteristics. Therefore, animals requiring multiple treatments for BRD appear to maintain the potential to produce carcasses with similar value to healthy animals given the additional days and intake energy required. The exception appears to be marbling score, which tended to decrease linearly as the number of BRD treatments increased. Due to the observed compensatory response, we conclude that isolating cattle with multiple BRD treatments and extending the days on feed for those animals may be a viable management alternative for increasing the carcass value of animals treated for BRD. Although retail shelf-life might be decreased, characteristics of tenderness and palatability of meat are minimally affected by BRD treatment during the preconditioning phase.
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